SEC 13F Intelligence

Kent Lake Capital LLC / ANIK

Kent Lake Capital LLC’s Anika Therapeutics Inc Position

Does Kent Lake Capital LLC own Anika Therapeutics Inc (ANIK)? Not currently — the last reported position was 98.6K shares worth $2M in Q2 2022; the fund’s latest 13F (Q2 2024) no longer reports it.

Position Value
$2M
Q2 2022
Shares
98.6K
% of Portfolio
+1.21%
Quarters Held
1
position exited

Position History ANIK

Reported value by quarter
Q2 ’22: $2MQ2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202298.6K$2M+1.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kent Lake Capital LLC’s full portfolio or all institutional holders of ANIK.